-
Thailand Emerges as Southeast Asia's Prime Destination for Biotechnology Development
prnasia
November 15, 2017
Biotechnology in Thailand has been through over three decades of development.
-
Amgen and Science Centre Singapore launch the Amgen Biotech Experience (ABE)
pharmaasia
November 08, 2017
The long-established Amgen innovative science education programme gives local secondary students real-world hands-on biotechnology lab experience.
-
Nobel Laureate honoured by Japan for contribution in Science and technology
biospectrumasia
September 01, 2017
The molecular biology pioneer won the Nobel Prize in physiology/medicine in 2002.
-
The VACCINE DEBATE
biospectrumasia
July 27, 2017
Various vaccines are being designed to treat auto-immune diseases or allergic disorders too. The field of vaccine research, thus, holds a bright future and will have a huge market in terms of demand
-
Surface Oncology enters licence agreement to use Ligand’s OmniAb platform
pharmaceutical-technology
June 06, 2017
Ligand Pharmaceuticals has entered a worldwide licence agreement for US-based biotechnology company Surface Oncology to use its OmniAb platform.
-
Amgen showcases a legacy of science, innovation and collaboration in Cambridge
worldpharmanews
June 05, 2017
Now one of the world's leading independent biotechnology companies, Amgen has expanded its presence in Cambridge and today hosted members of the Massachusetts life sciences community...
-
IT Transformation and Cloud Content Management for MedTech, Biotechnology and Pharmaceutical Compani
worldpharmanews
June 01, 2017
Due to evolving technology and accelerated growth in research and development activities, cloud computing and IT business technology have increased rapidly.
-
Bioverativ to purchase True North Therapeutics for $400m
pharmaceutical-technology
May 27, 2017
Global biotechnology company Bioverativ has entered a definitive agreement to acquire US-based company True North Therapeutics for $400m.
-
Novogen awarded grant of up to A$3 million by Australian Federal Government for novel drug discovery
pharmaasia
April 12, 2017
The grant was awarded to fund development of a next-generation anti-tropomyosin program, which is intended to provide potential new therapies for cancer.
-
Indian FDA Approves the First Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN(R)
en-cphi.cn
April 07, 2017
A first-of-its-kind Indian biotechnology company, APAC Biotech, was granted with a commercial license by Indian FDA (CDSCO - Central Drugs Standard Control Organization) to market product, APCEDEN®...